The interactions of docetaxel with tumor microenvironment

R Gupta, MM Kadhim, AT Jalil, MQ Alasheqi… - International …, 2023 - Elsevier
There are several interactions within the tumor microenvironment (TME) that affect the
response of cancer cells to therapy. There are also a large number of cells and secretions in …

A review of progress in o-aminobenzamide-based HDAC inhibitors with dual targeting capabilities for cancer therapy

WX Zhang, J Huang, XY Tian, YH Liu, MQ Jia… - European Journal of …, 2023 - Elsevier
Histone deacetylases, as a new class of anticancer targets, could maintain homeostasis by
catalyzing histone deacetylation and play important roles in regulating the expression of …

Discovery of novel N-benzylarylamide-dithiocarbamate based derivatives as dual inhibitors of tubulin polymerization and LSD1 that inhibit gastric cancers

XY Yuan, CH Song, XJ Liu, X Wang, MQ Jia… - European Journal of …, 2023 - Elsevier
In this work, N-benzylarylamide-dithiocarbamate based derivatives were designed,
synthesized, and their biological activities as anticancer agents were explored. Some of the …

Discovery of novel coumarin-indole derivatives as tubulin polymerization inhibitors with potent anti-gastric cancer activities

J Song, YF Guan, WB Liu, CH Song, XY Tian… - European Journal of …, 2022 - Elsevier
Novel coumarin-indole derivatives were designed, synthesized and evaluated as tubulin
polymerization inhibitors targeting the colchicine binding site. Among these compounds …

Design and synthesis of new trimethoxylphenyl-linked combretastatin analogues loaded on diamond nanoparticles as a panel for ameliorated solubility and …

I Zaki, AMY Moustafa, BY Beshay… - Journal of enzyme …, 2022 - Taylor & Francis
A new series of vinyl amide-, imidazolone-, and triazinone-linked combretastatin A-4
analogues have been designed and synthesised. These compounds have been evaluated …

An update on the recent advances and discovery of novel tubulin colchicine binding inhibitors

H Weng, J Li, H Zhu, KF Carver Wong… - Future Medicinal …, 2023 - Future Science
Microtubules, formed by α-and β-tubulin heterodimer, are considered as a major target to
prevent the proliferation of tumor cells. Microtubule-targeted agents have become …

[HTML][HTML] The microtubule cytoskeleton: An old validated target for novel therapeutic drugs

L Lafanechère - Frontiers in Pharmacology, 2022 - frontiersin.org
Compounds targeting microtubules are widely used in cancer therapy with a proven efficacy.
However, because they also target non-cancerous cells, their administration leads to …

Indazole-based microtubule-targeting agents as potential candidates for anticancer drugs discovery

D Pal, I Song, SD Warkad, K Song, GS Yeom… - Bioorganic …, 2022 - Elsevier
Tremendous research is focused on developing novel drug candidates targeting
microtubules to inhibit their function in several cellular processes, including cell division. In …

Recent advances on the structural modification of parthenolide and its derivatives as anticancer agents

LIU Xingchen, W Xiaobing - Chinese Journal of Natural Medicines, 2022 - Elsevier
Parthenolide (PTL) is a sesquiterpene lactone derived from medicinal plant feverfew
(Tanacetum parthenium). Recent studies have demonstrated that it has multiple …

The dual FAK-HDAC inhibitor MY-1259 displays potent activities in gastric cancers in vitro and in vivo

J Song, X Liu, YF Zhang, XY Tian, MY Deng… - Bioorganic …, 2023 - Elsevier
Epigenetic regulation and Focal adhesion kinase (FAK) are considered to be two important
targets for the development of antitumor drugs. Studies have shown that the combination of …